Maze Therapeutics, Inc. (MAZE)
Nasdaq: MAZE · CIK 0001842295 · United States
Every official Maze Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open MAZE filings
Maze Therapeutics, Inc. documents
- Maze Therapeutics, Inc. 10-K 2026MAZE 10-K 2026: annual report for fiscal 2026
- Maze Therapeutics, Inc. 10-K 2025MAZE 10-K 2025: annual report for fiscal 2025
- Maze Therapeutics, Inc. 10-K 2024MAZE 10-K 2024: annual report for fiscal 2024
- Maze Therapeutics, Inc. 10-K 2023MAZE 10-K 2023: annual report for fiscal 2023
- Maze Therapeutics, Inc. 10-K 2022MAZE 10-K 2022: annual report for fiscal 2022
- Maze Therapeutics, Inc. 10-Q 2026MAZE 10-Q 2026: quarterly report for fiscal 2026
- Maze Therapeutics, Inc. 10-Q 2025MAZE 10-Q 2025: quarterly report for fiscal 2025
- Maze Therapeutics, Inc. 10-Q 2024MAZE 10-Q 2024: quarterly report for fiscal 2024
- Maze Therapeutics, Inc. 10-Q 2023MAZE 10-Q 2023: quarterly report for fiscal 2023
- Maze Therapeutics, Inc. 10-Q 2022MAZE 10-Q 2022: quarterly report for fiscal 2022
- Maze Therapeutics, Inc. 8-K 2026MAZE 8-K 2026: current report for fiscal 2026
- Maze Therapeutics, Inc. 8-K 2025MAZE 8-K 2025: current report for fiscal 2025
- Maze Therapeutics, Inc. 8-K 2024MAZE 8-K 2024: current report for fiscal 2024
- Maze Therapeutics, Inc. 8-K 2023MAZE 8-K 2023: current report for fiscal 2023
- Maze Therapeutics, Inc. 8-K 2022MAZE 8-K 2022: current report for fiscal 2022
- Maze Therapeutics, Inc. DEF 14A 2026MAZE DEF 14A 2026: proxy statement for fiscal 2026
- Maze Therapeutics, Inc. DEF 14A 2025MAZE DEF 14A 2025: proxy statement for fiscal 2025
- Maze Therapeutics, Inc. DEF 14A 2024MAZE DEF 14A 2024: proxy statement for fiscal 2024
- Maze Therapeutics, Inc. DEF 14A 2023MAZE DEF 14A 2023: proxy statement for fiscal 2023
- Maze Therapeutics, Inc. DEF 14A 2022MAZE DEF 14A 2022: proxy statement for fiscal 2022
- Maze Therapeutics, Inc. Form 4 2026MAZE Form 4 2026: insider trading filing for fiscal 2026
- Maze Therapeutics, Inc. Form 4 2025MAZE Form 4 2025: insider trading filing for fiscal 2025
- Maze Therapeutics, Inc. Form 4 2024MAZE Form 4 2024: insider trading filing for fiscal 2024
- Maze Therapeutics, Inc. Form 4 2023MAZE Form 4 2023: insider trading filing for fiscal 2023
- Maze Therapeutics, Inc. Form 4 2022MAZE Form 4 2022: insider trading filing for fiscal 2022
- Maze Therapeutics, Inc. S-1 2026MAZE S-1 2026: registration statement for fiscal 2026
- Maze Therapeutics, Inc. S-1 2025MAZE S-1 2025: registration statement for fiscal 2025
- Maze Therapeutics, Inc. S-1 2024MAZE S-1 2024: registration statement for fiscal 2024
- Maze Therapeutics, Inc. S-1 2023MAZE S-1 2023: registration statement for fiscal 2023
- Maze Therapeutics, Inc. S-1 2022MAZE S-1 2022: registration statement for fiscal 2022
- Maze Therapeutics, Inc. 13F 2026MAZE 13F 2026: institutional holdings for fiscal 2026
- Maze Therapeutics, Inc. 13F 2025MAZE 13F 2025: institutional holdings for fiscal 2025
- Maze Therapeutics, Inc. 13F 2024MAZE 13F 2024: institutional holdings for fiscal 2024
- Maze Therapeutics, Inc. 13F 2023MAZE 13F 2023: institutional holdings for fiscal 2023
- Maze Therapeutics, Inc. 13F 2022MAZE 13F 2022: institutional holdings for fiscal 2022
More companies